Skip to search formSkip to main contentSkip to account menu

Implanon

Known as: Nourypharma brand of 3-keto-desogestrel, Organon brand of 3-keto-desogestrel 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objective. Recently, we found decreased levels of C-reactive protein (CRP) during use of the low-dosed contraceptive implant… 
2008
2008
Abstract Our study has shown that ultrasound-guided localisation and removal of Implanon™ rods is safe, practical and highly… 
Review
2004
Review
2004
Aim The primary objective of the study was to evaluate the continuation rates of a relatively new long-acting method of… 
Review
2004
Review
2004
AIM The primary objective of the study was to evaluate the continuation rates of a relatively new long-acting method of… 
2003
2003
This is a case report of an Implanon® contraceptive device that was impalpable after insertion and a discussion of the management… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT Implanon®, a novel contraceptive implant containing the progestogen, etonogestrel (68 mg), provides highly effective… 
Review
1999
Review
1999
This paper compares current clinical trials experience of Implanon with that of Norplant the other implantable progestogen… 
Highly Cited
1998